Next Article in Journal
Polyelectrolytes: Influence on Evaporative Self-Assembly of Particles and Assembly of Multilayers with Polymers, Nanoparticles and Carbon Nanotubes
Next Article in Special Issue
Mimicking the Nanostructure of Bone: Comparison of Polymeric Process-Directing Agents
Previous Article in Journal
Glucan Particle Encapsulated Rifampicin for Targeted Delivery to Macrophages
Previous Article in Special Issue
Synthesis of Propargyl-Terminated Heterobifunctional Poly(ethylene glycol)
Polymers 2010, 2(4), 709-718; doi:10.3390/polym2040709

Simvastatin Release from Poly(lactide-co-glycolide) Membrane Scaffolds

1 Centre for Regenerative Medicine, Department of Chemical Engineering, University of Bath, Claverton Down, Bath, BA2 7AY, UK 2 School of Materials, Materials Science Centre, University of Manchester, Grosvenor Street, Manchester M13 9PL, UK
* Author to whom correspondence should be addressed.
Received: 15 November 2010 / Revised: 30 November 2010 / Accepted: 8 December 2010 / Published: 9 December 2010
(This article belongs to the Special Issue Biofunctional Polymers for Medical Applications)
View Full-Text   |   Download PDF [108 KB, 10 December 2010; original version 9 December 2010]   |   Browse Figures


Statins, a group of potent inhibitors of 3-hydroxy-3-methylglutaryl Coenzyme A reductase in cholesterol biosynthesis pathway, have been widely used as a cholesterol lowering drug. The plieotrophic effect of statins on bone metabolism in long-term usage has been begun to be studied during recent years and several in vitro and in vivo studies have demonstrated the ability of statins to promote expression of bone morphogenetic protein-2 (BMP-2), inhibition of osteoclast differentiation and reduction of osteoporotic fractures risk. The high liver specificity and low oral bioavailability of statins, leading to poor peripheral distribution, are the main obstacles to benefit anabolic effects of hydrophobic statins on bone formation. Therefore, developing new administration roots for direct delivery to achieve optimum concentration in the bone microenvironment is of interest. Here we present and compare two approaches of combining statins with bone tissue engineering scaffolds. Simvastatin was combined with a poly(lactide-co-glycolide) (PLGA) membrane scaffold for diffusion-controlled release by dissolving simvastatin (dis-sim) in the membrane casting dope, and for degradation-controlled release by covalently bonding saponifiedsimvastatin (sap-sim) to the PLGA in the spinning dope. Rheological and concentration-dependent membrane morphology changes were observed with saponifiedsimvastatin, suggesting ester bond cleavage and covalent bonding of the statin to the PLGA, but not with dissolved simvastatin. Dissolved simvastatin membranes showed a logarithmic decay release profile while the saponifiedsimvastatin membranes showed constant release. It can be concluded that the covalent bonding of simvastatinto PLGA scaffolds is showing potential for use as a controlled releasescaffold for bone tissue engineering.
Keywords: PLGA; membrane; scaffold; statin; controlled release; bone tissue engineering PLGA; membrane; scaffold; statin; controlled release; bone tissue engineering
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Rashidi, H.; Ellis, M.J.; Cartmell, S.H.; Chaudhuri, J.B. Simvastatin Release from Poly(lactide-co-glycolide) Membrane Scaffolds. Polymers 2010, 2, 709-718.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Polymers EISSN 2073-4360 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert